Move from tech to Nickel exploration/mining company

off topic to friends of harry and the boys in dark glasses

for years and years glaxo survived on its reputation and mainly zantac-profits --you only really need one blockbuster compound to reach the global markets - minster pharma have two potential blockbuster compounds and dr Sharpe is very confident of winning ultimate regulatory approval ---now i dont see any reason why myself and all other shareholders should not trust and support him ? ask why would gsk risk its own reputation and back him in granting sharpe /minster the licence -if they didn't already have a great faith and confidence in his ability as a pharmacist --as a boy in dark glasses --its not harry punters reputation on the line here --its glaxo/smithkline

harry punter - 21 Dec'05 - 01:47 - 2180 of 2181 edit